JENNY HOUZENGA: Open Payments
NPI 1538835350 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,811 in 65 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,811
Food & beverage: $1,699Education: $113
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 7 | $386 |
| Vanda Pharmaceuticals Inc. | 13 | $361 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $333 |
| Axsome Therapeutics, Inc. | 5 | $213 |
| Otsuka America Pharmaceutical, Inc. | 9 | $194 |
| Corium, LLC | 4 | $56 |
| Janssen Pharmaceuticals, Inc | 3 | $47 |
| ABBVIE INC. | 2 | $47 |
| Alkermes, Inc. | 2 | $42 |
| Lundbeck LLC | 1 | $27 |
Products named: FANAPT, CAPLYTA, UZEDY, Auvelity, REXULTI, ABILIFY MAINTENA, Azstarys, INVEGA SUSTENNA.
Industry payments across IN — which companies pay providers there.
